Literature DB >> 22702655

Acromegalic cardiomyopathy in an extensively admixed population: is there a role for GH/IGF-I axis?

Gilvan Cortês Nascimento1, Marina Torres de Oliveira, Viviane Chaves Carvalho, Maria Honorina Cordeiro Lopes, Adriana Maria Guimarães Sá, Marinilde Teles Souza, Adalgisa de Souza Paiva Ferreira, Pedro Antônio Muniz Ferreira, Manuel dos Santos Faria.   

Abstract

BACKGROUND: A specific acromegaly-related cardiomyopathy has been described in the literature, largely in Caucasians, which is independent of other risk factors, mainly hypertension.
OBJECTIVE: This study assessed the cardiac changes in acromegalics of significant ethnic diversity and also the relevance of the aetiopathogenic factors involved, such as disease activity and hypertension.
DESIGN: It is a cross-sectional study with a comparative control group. PATIENTS AND METHODS: In this study, 37 acromegalic patients (20 Intermediate-skinned (IS), 14 Dark-skinned (DS) and three Light-skinned (LS) individuals) and 74 controls matched by age, gender and hypertension were evaluated. Cardiac morphology and function were addressed using echocardiography parameters.
RESULTS: The mean age of patients was 46.9 ± 12.8 years, with 67.6% being women and 43.2% hypertensive. The prevalence of left ventricular hypertrophy (LVH) between acromegalics was 56.8% vs 10.8% in the controls (P < 0.001). About 86% of patients with LVH had active disease (P = 0.023). Logistic regression revealed that disease activity presented a stronger association (OR = 5.925; CI = 1.085-32.351; P = 0.040) with LVH than hypertension (OR = 3.237; CI = 0.702-14.924; P = 0.132). When DS acromegalics were compared with IS ones, no statistically significant differences were observed.
CONCLUSION: Chronically hyperactive somatotropic axis remains as an independent and determining factor in the development of left ventricular hypertrophy, as it is more associated with this condition than hypertension in a largely admixed population with a high degree of African ancestry.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22702655     DOI: 10.1111/j.1365-2265.2012.04472.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

2.  Two-dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain.

Authors:  I C M Volschan; L Kasuki; C M S Silva; M L Alcantara; R M Saraiva; S S Xavier; M R Gadelha
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

3.  Serum Elabela level is significantly increased in patients with acromegaly.

Authors:  Hilmi Erdem Sumbul; Erdinc Gulumsek; Begum Seyda Avci; Nurettin Ay; Ramazan Azim Okyay; Ahmet Riza Sahin; Jeffrey Gold; Akkan Avci; Mevlut Koc
Journal:  Ir J Med Sci       Date:  2022-06-04       Impact factor: 1.568

4.  ECHOCARDIOGRAPHIC MYOCARDIAL CHANGES IN ACROMEGALY: A CROSS-SECTIONAL ANALYSIS IN A TERTIARY CENTER IN BULGARIA.

Authors:  E Natchev; A Kundurdjiev; N Zlatareva; S Vandeva; G Kirilov; T Kundurzhiev; S Zacharieva
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

Review 5.  Advances in Research on the Cardiovascular Complications of Acromegaly.

Authors:  Han Yang; Huiwen Tan; He Huang; Jianwei Li
Journal:  Front Oncol       Date:  2021-04-02       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.